In 2015, NICE said that BioMarin's Vimizim could be used to treat patients with the ultra-rare disease Morquio A syndrome ... of respiratory failure and heart problems. The final draft guidance ...
ICYMI, the Benefits Committee (BenCom) of the PhilHealth board has approved the new enhanced benefit packages for heart ... disease, pompe disease, fabry disease, Hunter syndrome, morquio syndrome ...